Effect of Atorvastatin on Inflammatory Factors and Carotid Atherosclerosis Plaques in Patients with Acute Coronary Syndrome
Chen Qiao-lian, Zhong Gen-ming
Abstract
Chen Qiao-lian, Zhong Gen-ming
Abstract
OBJECTIVE: To investigate the effects of atorvastatin on inflammatory factors and carotid atherosclerotic plaques in patients with acute coronary syndrome(ACS).METHODS: 68 ACS patients were randomly divided into atorvastatin group and control group.Atorvastatin group was treated with oral atorvastatin tablets 20 mg·d-1 for 20 weeks.The treatments of control group were same to those of atorvastatin group except for oral administration of atorvastatin.RESULTS: After 20 weeks of treatment,the plasma levels of hs-CRP and IL-18 decreased significantly(P0.05 or P0.01),compared with before treatment.And the decrease of atorvastatin group was more evident(P0.05).After 20 weeks of treatment,thickness and plaque size,IMT of carotid artery(IMT) in atorvastatin group was significantly reduced(P0.05),while there was no significant change in quantity of plaque(P0.05).The size,thickness,quantity and IMT of plaque in control group had no significant difference before and after treatment(P0.05).CONCLUSION: Atorvastatin has anti-inflammatory effect on the ACS and can improve blood vessel plaque inflammation.It can block and reverse coronary atherosclerotic plaques.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE: To investigate the effects of atorvastatin on inflammatory factors and carotid atherosclerotic plaques in patients with acute coronary syndrome(ACS).METHODS: 68 ACS patients were randomly divided into atorvastatin group and control group.Atorvastatin group was treated with oral atorvastatin tablets 20 mg·d-1 for 20 weeks.The treatments of control group were same to those of atorvastatin group except for oral administration of atorvastatin.RESULTS: After 20 weeks of treatment,the plasma levels of hs-CRP and IL-18 decreased significantly(P0.05 or P0.01),compared with before treatment.And the decrease of atorvastatin group was more evident(P0.05).After 20 weeks of treatment,thickness and plaque size,IMT of carotid artery(IMT) in atorvastatin group was significantly reduced(P0.05),while there was no significant change in quantity of plaque(P0.05).The size,thickness,quantity and IMT of plaque in control group had no significant difference before and after treatment(P0.05).CONCLUSION: Atorvastatin has anti-inflammatory effect on the ACS and can improve blood vessel plaque inflammation.It can block and reverse coronary atherosclerotic plaques.
Key concepts: Atorvastatin, Medicine, Acute coronary syndrome, Internal medicine, Cardiology, Inflammation, Gastroenterology, Myocardial infarction